Solara Active Pharma Sciences Profile
Key Indicators
- Authorised Capital ₹ 120.00 Cr
as on 23-06-2024
- Paid Up Capital ₹ 36.00 Cr
as on 23-06-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1,724.40 Cr
as on 23-06-2024
- Satisfied Charges ₹ 2,310.69 Cr
as on 23-06-2024
- Revenue 13.90%
(FY 2023)
- Profit 62.07%
(FY 2023)
- Ebitda 66.82%
(FY 2023)
- Net Worth -1.57%
(FY 2023)
- Total Assets -1.86%
(FY 2023)
About Solara Active Pharma Sciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 541540 and on the National Stock Exchange(NSE) under SOLARA.
The Corporate was formerly known as Ssl Pharma Sciences Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 120.00 Cr and a paid-up capital of Rs 36.00 Cr.
The company currently has active open charges totaling ₹1,724.40 Cr. The company has closed loans amounting to ₹2,310.69 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Solara Active Pharma Sciences Limited India are Arun Baskaran as Cfo, Suddapalli Muralikrishna as Company Secretary, and Poorvank Purohit as Ceo. Arun Pillai, Ramakrishnan Rajagopal, Kartheek Raju, and Six other members serve as directors at the Company.
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Solara Active Pharma Sciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Baskaran | CFO | 21-Mar-2024 | Current |
Poorvank Purohit  | Managing Director | 05-Jul-2023 | Current |
| Suddapalli Muralikrishna | Company Secretary | 26-Mar-2018 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakrishnan Rajagopal | Director | 11-Apr-2018 | Current |
Rajendra Srivastava  | Director | Current | |
| Kausalya Santhanam | Director | 11-Apr-2018 | Current |
| Ankur Thadani | Director | 16-May-2019 | Current |
| Arun Pillai | Director | 04-Aug-2021 | Current |
| Kartheek Raju | Director | 05-Jul-2023 | Current |
Financial Performance and Corporate Structure Insights of Solara Active Pharma Sciences.
Solara Active Pharma Sciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.9% increase. The company also saw a substantial improvement in profitability, with a 62.07% increase in profit. The company's net worth dipped by a decrease of 1.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solara Active Pharma Sciences?
In 2022, Solara Active Pharma Sciences had a promoter holding of 39.71% and a public holding of 60.29%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 28 Sep 2022 | ₹75.00 Cr | Open |
Yes Bank Limited Creation Date: 28 Sep 2022 | ₹65.00 Cr | Open |
Others Creation Date: 22 Nov 2021 | ₹150.00 Cr | Open |
How Many Employees Work at Solara Active Pharma Sciences?
Solara Active Pharma Sciences has a workforce of 1656 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solara Active Pharma Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solara Active Pharma Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
